Invizyne Technologies (NASDAQ:IZTC) Trading Up 4.7% - Here's Why

Key Points

• Invizyne Technologies Inc. (NASDAQ:IZTC) saw its shares increase by 4.7% on Friday, trading between $12.99 and $9.95.
• Significant institutional investment was noted, with firms like BNP Paribas, Geode Capital Management, and Citadel Advisors acquiring new positions in the company during the fourth quarter.
• Invizyne Technologies specializes in cell-free enzyme-based biomanufacturing, aiming to transform renewable resources into valuable biochemicals.

Invizyne Technologies Inc. (NASDAQ:IZTC - Get Free Report) shot up 4.7% during mid-day trading on Friday . The stock traded as high as $12.99 and last traded at $9.95. 36,869 shares traded hands during mid-day trading, a decline of 2% from the average session volume of 37,647 shares. The stock had previously closed at $9.50.

Invizyne Technologies Price Performance

The firm's 50 day moving average price is $11.71 and its 200-day moving average price is $13.03.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Citadel Advisors LLC bought a new position in shares of Invizyne Technologies in the 4th quarter valued at about $456,000. BNP Paribas Financial Markets bought a new position in Invizyne Technologies during the 4th quarter worth approximately $35,000. Finally, Geode Capital Management LLC bought a new position in Invizyne Technologies during the 4th quarter worth approximately $277,000.

About Invizyne Technologies

Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.